Background: Alzheimer's disease (AD) is associated with complex pathophysiology including synaptic dysregulation, compromised neurotrophic signaling, deficits in autophagic flux and neuroinflammation). Skeletal muscle regulates many brain functions relevant to aging, by activating the muscle-to-brain axis through the secretion of skeletal muscle originating factors (myokines) with cellular-modifying, neuro and geroprotective properties. Our group developed transgenic mice that overexpress the skeletal muscle human Transcription Factor EB (TFEB), a master regulator of lysosomal-to-nucleus signaling, resulting in enhanced proteostasis and neuroprotection in a Tau mouse model. However, the precise mechanisms remain unknown. Therefore, we further validated these effects in an AD amyloid β (Aβ) mouse model and investigated the underlying mechanism.

Method: We crossbred female 5xFAD mice, carrying 5 AD familial mutations, with transgenic mice that overexpress human TFEB to create 5xFAD;cTFEB;HSA-Cre (3FA) mice. At 4 and 8 months of age, we analyzed Aβ plaque accumulation through immunohistochemistry and conducted western blot analysis for multiple synaptic markers, growth factors, autophagic/lysosomal regulators, and myokines across the muscle-to-brain axis. We also performed a battery of neurocognitive tests (open field, the Barnes maze, and fear conditioning) at 8 months of age, when this model has previously been reported to demonstrate robust cognitive impairment.

Result: Skeletal muscle-targeted TFEB expression reduced Aβ plaque accumulation in cortices of 4-month-old female mice. Furthermore, muscle-TFEB expression altered synaptic-associated gene transcriptional signatures in hippocampi, and rescued behavioral deficits in 8-month-old female 5xFAD mice. Western blots of cortex from 8-month-old female 3FA mice confirmed a rescue of several synaptic markers including SNAP25, synaptophysin I, synaptotagmin I and PSD95, neurotrophic factors such as BDNF and autophagic/lysosomal regulators such as Cathepsin D and B, prosaposin (PSAP) and saposin C. Levels of PSAP (a recently identified exercise-responsive myokine) were also increased in skeletal muscle, plasma and cortices, suggesting that PSAP may act as a novel myokine involved in muscle-to-brain rescue mechanisms. scle, plasma and cortices of 8-month-old female mice, suggesting that PSAP may act as a novel myokine involved in muscle-to-brain rescue mechanisms.

Conclusion: Skeletal muscle directly regulates CNS function and health in the 5xFAD model regulating synaptic integrity, neurotrophic signaling and autophagic flux, potentially through release of CNS-targeting myokines.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.094857DOI Listing

Publication Analysis

Top Keywords

skeletal muscle
20
8-month-old female
12
neurotrophic signaling
8
autophagic flux
8
muscle-to-brain axis
8
mice
8
transgenic mice
8
mice overexpress
8
mouse model
8
female 5xfad
8

Similar Publications

Background: Increased levels of inflammation in cancer patients and survivors can make them more prone to muscle wasting and sarcopenia. Diet can be an appropriate treatment for alleviating patient complications. Therefore, this study was performed to determine the association between sarcopenia and its components with the dietary inflammatory index (DII) among breast cancer survivors.

View Article and Find Full Text PDF

Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan.

Skelet Muscle

January 2025

Department of Molecular Physiology and Biophysics, and Department of Neurology, Howard Hughes Medical Institute, Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.

Background: Maintaining the connection between skeletal muscle fibers and the surrounding basement membrane is essential for muscle function. Dystroglycan (DG) serves as a basement membrane extracellular matrix (ECM) receptor in many cells, and is also expressed in the outward-facing membrane, or sarcolemma, of skeletal muscle fibers. DG is a transmembrane protein comprised of two subunits: alpha-DG (α-DG), which resides in the peripheral membrane, and beta-DG (β-DG), which spans the membrane to intracellular regions.

View Article and Find Full Text PDF

This review comprehensively explores the critical role of calcium as an essential small-molecule biomessenger in skeletal muscle function. Calcium is vital for both regulating muscle excitation-contraction coupling and for the development, maintenance, and regeneration of muscle cells. The orchestrated release of calcium from the endoplasmic reticulum (ER) is mediated by receptors such as the ryanodine receptor (RYR) and inositol 1,4,5-trisphosphate receptor (IP3R), which is crucial for skeletal muscle contraction.

View Article and Find Full Text PDF

Association between daily sitting time and sarcopenia in the US population: a cross-sectional study.

Arch Public Health

January 2025

Department of Second Orthopedics, First People's Hospital of Jiashan County, Tiyu South Road 1218#, Jiashan County, Zhejiang, China.

Background: Sarcopenia is an age-related syndrome marked by a gradual decline in skeletal muscle mass and function. While various factors influencing sarcopenia have been studied, the link between daily sedentary time and sarcopenia remains underexplored.

Method: This study analyzed the association between daily sitting time and sarcopenia using data from the National Health and Nutrition Examination Survey (NHANES 2011-2018).

View Article and Find Full Text PDF

Background: Transient receptor potential cation channel subfamily V member 2 (TRPV2) functions as a stretch-sensitive calcium channel, with overexpression in the sarcolemma of skeletal and cardiac myocytes leading to detrimental calcium influx and triggering muscle degeneration. In our previous pilot study, we showed that tranilast, a TRPV2 inhibitor, reduced brain natriuretic peptide levels in two patients with muscular dystrophy and advanced heart failure. Building on this, we performed a single-arm, open-label, multicenter study herein to evaluate the safety and efficacy of tranilast in the treatment of advanced heart failure in patients with muscular dystrophy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!